Skip to main content

Table 5 Characteristics and clinical outcomes of uterine adenosarcoma (literature review and present study)

From: Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience

Source

No. of patients

Age

Stage I of FIGO classification

SO

Recurrence

SOā€‰+ā€‰recurrence

Time to recurrencea

F/U months

Caroll, et al. [2]

74

54

59 (80%)

34 (42%)

34 (46%)

24 (71%)

18.3

56.5

Tanner et al. [5]

19

55

15 (79%)

5 (26%)

5 (26%)

4 (80%)

20.1

72.9

Bernard et al. [4]

64

61

47 (73%)

30 (47%)

16 (36%)

11 (69%)

21.2

23.8

Kaku et al. [9]

31

ND

ND

17 (55%)

9 (30%)

ND

ND

38.3

Present study

31

44.5

31 (100%)

10 (32%)

5 (16%)

4 (80%)

21.6

32.0

  1. aMonths
  2. SO sarcomatous overgrowth, F/U follow-up, ND not defined